Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

In the early days of therapeutic apheresis, the capability of processing blood with therapeutic
intent gave rise to enthusiasm, sometimes spurred and sometimes tempered by the results …

Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …

Extracorporeal photopheresis (ECP) may represent an alternative to immunosuppression,
as a means of reducing rejection after thoracic organ transplantation. The mechanism by …

Extracorporeal photopheresis-induced immune tolerance: a foc... : Current Opinion in Organ
Transplantation Extracorporeal photopheresis-induced immune tolerance: a focus on …

Current understanding of the immunomodulatory mechanisms of extracorporeal
photopheresis (ECP) is that 8-methoxypsoralen incubation and UVA exposure of peripheral …

Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell
transplantation and a major cause of morbidity and mortality in affected patients. Especially …

Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …

Extracorporeal photopheresis (ECP) has proven effective in the treatment of several
diseases, including acute and chronic graft‐versus‐host disease (GVHD) after allogeneic …

Aim: To present well-known and disputable mechanisms of the effects of extracorporeal
photopheresis (ECP) in heterogeneous clinical conditions, as well as to demonstrate its …